
An overview on HMGB1 inhibitors as potential therapeutic agents in HMGB1-related pathologies
Keywords: HMGB1; HMGB1-receptors; Small-molecule inhibitors; Peptide/protein inhibitors; DNA-based inhibitorsEP, ethyl pyruvate; GL, glycyrrhizin; HMGB, High-Mobility Group Box; IL, interleukin; I/R, ischemia–reperfusion; LPS, lipopolysaccharide; ODN, oligodeoxyrib